Posterior Wall Substrate Modification Using Irreversible Electroporation for Paroxysmal Atrial Fibrillation
Public ClinicalTrials.gov record NCT06364215. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Posterior Wall Substrate Modification Using Irreversible Electroporation for the Treatment of Paroxysmal Atrial Fibrillation
Study identification
- NCT ID
- NCT06364215
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Jorge Romero
- Other
- Enrollment
- 198 participants
Conditions and interventions
Conditions
Interventions
- Farapulse PFA, Pulmonary Vein Isolation alone Device
- Farapulse PFA, Pulmonary Vein Isolation and Left atrial Posterior Wall Isolation Device
Device
Eligibility (public fields only)
- Age range
- 21 Years to 90 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 7, 2024
- Primary completion
- Nov 15, 2025
- Completion
- Nov 15, 2025
- Last update posted
- May 14, 2026
2024 – 2025
United States locations
- U.S. sites
- 18
- U.S. states
- 13
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Grandview Medical Center | Birmingham | Alabama | 35243 | — |
| MedStar Washington Hospital Center | Washington D.C. | District of Columbia | 20010 | — |
| St. Vincent's Health System, Inc. d/b/a Ascension St. Vincent's | Jacksonville | Florida | 32204 | — |
| HCA Florida Mercy Hospital | Miami | Florida | 33133 | — |
| St. Luke's Boise Medical Center | Boise | Idaho | 83712 | — |
| Maine Medical Center | Portland | Maine | 04102 | — |
| Brigham and Women's Hospital | Boston | Massachusetts | 02115 | — |
| Lahey Hospital and Medical Center | Burlington | Massachusetts | 01805 | — |
| Corewell Health William Beaumont Hospital | Royal Oak | Michigan | 48073 | — |
| The Valley Hospital | Paramus | New Jersey | 07652 | — |
| North Shore University Hospital, Northwell Health | Manhasset | New York | 11030 | — |
| Doylestown Hospital | Doylestown | Pennsylvania | 18901 | — |
| Trident Medical Center | Charleston | South Carolina | 29406 | — |
| Medical University of South Carolina | Charleston | South Carolina | 29425 | — |
| Orion Medical | Houston | Texas | 77034 | — |
| Methodist Hospital-San Antonio | San Antonio | Texas | 78229 | — |
| University of Texas Health Science Center at San Antonio | San Antonio | Texas | 78229 | — |
| University of Washington Medical Center | Seattle | Washington | 98195 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06364215, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 14, 2026 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06364215 live on ClinicalTrials.gov.